EP3673906
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
16.3.2012:
14.5.2025:
19207540.6
:
15.3.2032:
15.3.2026
:
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
16.3.2012
14.5.2025
15.3.2026
:
Genzyme Corporation:
450 Water Street, Cambridge, MA 02141, US
:
BOURQUE, Elyse:
Cambridge, MA 02141, US
:
CELATKA, Cassandra:
Cambridge, MA 02141, US
:
HIRTH, Bradford:
Cambridge, MA 02141, US
:
METZ, Markus:
Cambridge, MA 02141, US
:
ZHAO, Zhong:
Cambridge, MA 02141, US
:
SKERLJ, Renato:
Cambridge, MA 02141, US
:
XIANG, Yibin:
Cambridge, MA 02141, US
:
JANCSICS, Katherine:
Cambridge, MA 02141, US
:
GOOD, Andrew:
Cambridge, MA 02141, US
:
MARSHALL, John:
Cambridge, MA 02141, US
:
CHENG, Seng:
Cambridge, MA 02141, US
:
SCHEULE, Ronald:
Cambridge, MA 02141, US
:
CABRERA-SALAZAR, Mario:
Cambridge, MA 02141, US
:
201161454034 P:
18.3.2011:
US
:
201261590711 P:
25.1.2012:
US
:
A61K 31/439, A61K 31/454, A61P 1/00, A61P 3/00, A61P 3/04, A61P 3/10, A61P 7/00, A61P 9/10, A61P 11/06, A61P 13/12, A61P 19/02, A61P 25/00, A61P 25/16, A61P 25/28, A61P 29/00, A61P 31/04, A61P 35/00, A61P 43/00, C07D 453/02, C07D 455/02, C07D 487/08